Ivermectin & Cancer Research
An evidence-organized overview of ivermectin cancer research, including preclinical findings, human evidence, limitations and safety considerations.
Published September 2, 2026 · Updated September 22, 2026 · By Website Editorial Team
What does the research show?
Ivermectin has attracted research interest for possible anticancer mechanisms in laboratory models. These findings are hypothesis-generating. A biological effect in cells or animals does not establish that ivermectin improves survival, tumor response or quality of life in people with cancer.
How this library grades evidence
Preclinical
Cell and animal research examining mechanisms and anticancer activity.
Human evidence
Clinical trials and observational evidence are treated separately from anecdotes.
Safety
Potential interactions, toxicity and dosing questions belong with appropriately licensed clinicians.
Frequently asked questions
Is ivermectin an approved cancer treatment?
Ivermectin is not established as an approved cancer treatment based on the evidence summarized on this site.
Do laboratory studies prove ivermectin treats cancer?
No. Preclinical studies can support further research but cannot establish clinical effectiveness in patients.
Should cancer treatment be changed based on this page?
No. Treatment decisions should be made with the patient's qualified oncology team.